Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 166

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 166
---
-1687.

Legal Proceedings

There are no pending
legal proceedings to which the Company is a party or in which any director, officer or affiliate of the Company, any owner of record
or beneficially of more than 5% of any class of voting securities of the Company, or security holder is a party adverse to the Company
or has a material interest adverse to the Company. The Company’s property is not the subject of any pending legal proceedings.

<div align='center'>104

MANAGEMENT</div>

Executive Officers, Directors and Key Personnel

The following table sets forth information regarding our executive
officers and directors:

| Name              |     | Age |     | Position                                        |
| Amir Avraham      |     |  49 |     | Interim Chief Executive Officer                 |
| Inna Martin       |     |  49 |     | President, Chief Operating Officer and Director |
| Arie Gordashnikov |     |  42 |     | Chief Financial Officer and Treasurer           |
| Bernard Bartal    |     |  60 |     | Chairman, Director                              |
| Matti Munk        |     |  53 |     | Director                                        |
| Yoram Drucker     |     |  59 |     | Director                                        |

Amir Avraham, 49,was appointed Chief
Executive Officer on an interim basis, on May 22, 2205 following Mr. Akunis resignation from such position. Since February 2024,
Mr. Avraham has been a financial consultant with the Company, on a part time basis. Prior to his appointment as interim Chief Executive
at the Company, since February 2017 he has been General Manager and Chief Financial Officer at OCON Therapeutics, a global biotech company
drug device company, operating in Israel and Switzerland, where he led strategic planning and capital raises totaling over $15 million
while managing legal, financial, and global activities. Prior thereto, he was from January 2013 to February 2017 he was Chief Financial
Officer at Secure Islands Technologies, a cybersecurity firm acquired by Microsoft, where he led financial operations across the US,
UK, and Switzerland, managed investor relations, and was instrumental in both a $20 million fundraising round and the Microsoft acquisition
process. From February 2008 to January 2013, he was Chief Financial Officer at Van Leer Technology Ventures, a venture company, where
he oversaw all financial reporting. Prior thereto from 2004 to